Bioengineered probiotics to control SARS-CoV-2 infection
The outbreak of 2019 novel corona virus disease (COVID-19) is now a global public health crisis and declared as a pandemic. Several recent studies suggest that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein binds to human angiotensin-converting enzyme 2 (ACE2). The inform...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Pensoft Publishers
2020-05-01
|
| Series: | Research Ideas and Outcomes |
| Subjects: | |
| Online Access: | https://riojournal.com/article/54802/download/pdf/ |